200 related articles for article (PubMed ID: 11285190)
1. Xeroderma pigmentosum group A gene action as a protection factor against 4-nitroquinoline 1-oxide-induced tongue carcinogenesis.
Ide F; Oda H; Nakatsuru Y; Kusama K; Sakashita H; Tanaka K; Ishikawa T
Carcinogenesis; 2001 Apr; 22(4):567-72. PubMed ID: 11285190
[TBL] [Abstract][Full Text] [Related]
2. p53 haploinsufficiency profoundly accelerates the onset of tongue tumors in mice lacking the xeroderma pigmentosum group A gene.
Ide F; Kitada M; Sakashita H; Kusama K; Tanaka K; Ishikawa T
Am J Pathol; 2003 Nov; 163(5):1729-33. PubMed ID: 14578172
[TBL] [Abstract][Full Text] [Related]
3. Grape seed extract and resveratrol prevent 4-nitroquinoline 1-oxide induced oral tumorigenesis in mice by modulating AMPK activation and associated biological responses.
Shrotriya S; Tyagi A; Deep G; Orlicky DJ; Wisell J; Wang XJ; Sclafani RA; Agarwal R; Agarwal C
Mol Carcinog; 2015 Apr; 54(4):291-300. PubMed ID: 24243690
[TBL] [Abstract][Full Text] [Related]
4. DNA repair-deficient Xpa and Xpa/p53+/- knock-out mice: nature of the models.
van Steeg H; de Vries A; van Oostrom CTh ; van Benthem J; Beems RB; van Kreijl CF
Toxicol Pathol; 2001; 29 Suppl():109-16. PubMed ID: 11695546
[TBL] [Abstract][Full Text] [Related]
5. p53 heterozygosity results in an increased 2-acetylaminofluorene-induced urinary bladder but not liver tumor response in DNA repair-deficient Xpa mice.
Hoogervorst EM; van Oostrom CT; Beems RB; van Benthem J; Gielis S; Vermeulen JP; Wester PW; Vos JG; de Vries A; van Steeg H
Cancer Res; 2004 Aug; 64(15):5118-26. PubMed ID: 15289314
[TBL] [Abstract][Full Text] [Related]
6. The role of the TP53 gene during rat tongue carcinogenesis induced by 4-nitroquinoline 1-oxide.
Minicucci EM; Ribeiro DA; da Silva GN; Pardini MI; Montovani JC; Salvadori DM
Exp Toxicol Pathol; 2011 Jul; 63(5):483-9. PubMed ID: 20385474
[TBL] [Abstract][Full Text] [Related]
7. p53 expression in various stages of 4-nitroquinoline 1-oxide induced carcinoma in the rat tongue.
Osugi Y
J Osaka Dent Univ; 1996 Dec; 30(1-2):29-35. PubMed ID: 9485768
[TBL] [Abstract][Full Text] [Related]
8. UV-induced skin carcinogenesis in xeroderma pigmentosum group A (XPA) gene-knockout mice with nucleotide excision repair-deficiency.
Tanaka K; Kamiuchi S; Ren Y; Yonemasu R; Ichikawa M; Murai H; Yoshino M; Takeuchi S; Saijo M; Nakatsu Y; Miyauchi-Hashimoto H; Horio T
Mutat Res; 2001 Jun; 477(1-2):31-40. PubMed ID: 11376684
[TBL] [Abstract][Full Text] [Related]
9. Suppressive effects of a selective cyclooxygenase-2 inhibitor, etodolac, on 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis.
Yamamoto K; Kitayama W; Denda A; Morisaki A; Kuniyasu H; Inoue M; Kirita T
Exp Toxicol Pathol; 2004 Dec; 56(3):145-51. PubMed ID: 15625783
[TBL] [Abstract][Full Text] [Related]
10. Effect of heterozygous loss of p53 on benzo[a]pyrene-induced mutations and tumors in DNA repair-deficient XPA mice.
van Oostrom CT; Boeve M; van Den Berg J; de Vries A; Dollé ME; Beems RB; van Kreijl CF; Vijg J; van Steeg H
Environ Mol Mutagen; 1999; 34(2-3):124-30. PubMed ID: 10529736
[TBL] [Abstract][Full Text] [Related]
11. Histological and immunohistochemical evaluation of the chemopreventive role of lycopene in tongue carcinogenesis induced by 4-nitroquinoline-1-oxide.
El-Rouby DH
Arch Oral Biol; 2011 Jul; 56(7):664-71. PubMed ID: 21216390
[TBL] [Abstract][Full Text] [Related]
12. Expression of receptor for advanced glycation end products during rat tongue carcinogenesis by 4-nitroquinoline 1-oxide and effect of a selective cyclooxygenase-2 inhibitor, etodolac.
Yamamoto K; Kitayama W; Denda A; Sasahira T; Kuniyasu H; Kirita T
Pathobiology; 2006; 73(6):317-24. PubMed ID: 17374970
[TBL] [Abstract][Full Text] [Related]
13. 1,4-phenylenebis(methylene)selenocyanate exerts exceptional chemopreventive activity in rat tongue carcinogenesis.
Tanaka T; Makita H; Kawabata K; Mori H; El-Bayoumy K
Cancer Res; 1997 Sep; 57(17):3644-8. PubMed ID: 9288763
[TBL] [Abstract][Full Text] [Related]
14. Importance of DNA repair in carcinogenesis: evidence from transgenic and gene targeting studies.
Ishikawa T; Ide F; Qin X; Zhang S; Takahashi Y; Sekiguchi M; Tanaka K; Nakatsuru Y
Mutat Res; 2001 Jun; 477(1-2):41-9. PubMed ID: 11376685
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor activity of grape juice concentrate in the rat tongue two-stage initiation-promotion protocol induced by 4-nitroquinoline 1-oxide.
de Jesus GP; Ribeiro FA; de Moura CF; Gollucke AP; Oshima CT; Ribeiro DA
Toxicol Mech Methods; 2014 May; 24(4):276-83. PubMed ID: 24401099
[TBL] [Abstract][Full Text] [Related]
16. Oral-specific ablation of Klf4 disrupts epithelial terminal differentiation and increases premalignant lesions and carcinomas upon chemical carcinogenesis.
Paparella ML; Abrigo M; Bal de Kier Joffe E; Raimondi AR
J Oral Pathol Med; 2015 Nov; 44(10):801-9. PubMed ID: 25605610
[TBL] [Abstract][Full Text] [Related]
17. XPA-deficiency in hairless mice causes a shift in skin tumor types and mutational target genes after exposure to low doses of U.V.B.
de Vries A; Berg RJ; Wijnhoven S; Westerman A; Wester PW; van Kreijl CF; Capel PJ; de Gruijl FR; van Kranen HJ; van Steeg H
Oncogene; 1998 Apr; 16(17):2205-12. PubMed ID: 9619829
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of the natural products indole-3-carbinol and sinigrin during initiation and promotion phases of 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis.
Tanaka T; Kojima T; Morishita Y; Mori H
Jpn J Cancer Res; 1992 Aug; 83(8):835-42. PubMed ID: 1399821
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of cyclooxygenase-2 protein in 4-nitroquinoline-1-oxide-induced rat tongue carcinomas and chemopreventive efficacy of a specific inhibitor, nimesulide.
Shiotani H; Denda A; Yamamoto K; Kitayama W; Endoh T; Sasaki Y; Tsutsumi N; Sugimura M; Konishi Y
Cancer Res; 2001 Feb; 61(4):1451-6. PubMed ID: 11245450
[TBL] [Abstract][Full Text] [Related]
20. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis in rats by flavonoids diosmin and hesperidin, each alone and in combination.
Tanaka T; Makita H; Ohnishi M; Mori H; Satoh K; Hara A; Sumida T; Fukutani K; Tanaka T; Ogawa H
Cancer Res; 1997 Jan; 57(2):246-52. PubMed ID: 9000563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
